Testosterone to Estradiol Ratio
Hormones marker
T:E2 Ratio
Testosterone to Estradiol Ratio
Ratio of total testosterone to estradiol, converted to conventional units (T ng/dL / E2 pg/mL). Reflects the androgenic-to-estrogenic balance. A low ratio indicates relative estrogen dominance; a very high ratio suggests over-suppressed estradiol.
PED Notes
Auto-calculated when both Testosterone and Estradiol are present in a blood test. IMPORTANT: This ratio is a guide, not a treatment target — E2 management should always be symptom-based. A ratio below 10 suggests significant estrogen dominance and may correlate with gyno risk, water retention, mood issues, and ED. A ratio above 40 suggests E2 may be too low relative to T, risking joint pain, poor libido, worsened lipids, and bone density loss. On TRT doses (100-200mg/week), typical ratios are 20-40. On blast doses, the ratio often drops below 20 because aromatization increases disproportionately at supraphysiological testosterone levels — this is expected and acceptable if asymptomatic. Studies show men with very low E2 (ratio >50) have 3x higher mortality than those with moderately elevated E2 (ratio 15-25). Do not chase a specific number — treat symptoms, not the ratio.
This ratio is auto-computed -- it is not directly manageable.
Adjust the individual components instead:
If ratio is too low (<10) -- relative estrogen dominance:
- See Estradiol (E2) management: symptom-based approach, SERM first-line, AI second-line
- Reduce aromatizable AAS dose if feasible
- Consider switching to less aromatising compounds (e.g., Primobolan, Masteron instead of Dianabol, high-dose Testosterone)
- Do NOT intervene if asymptomatic -- low ratios on blast are expected
If ratio is too high (>40) -- estradiol may be over-suppressed:
- Reduce or stop AI (Anastrozole/Exemestane) -- most common cause
- Allow E2 to recover naturally (takes 1-2 weeks after stopping AI)
- Signs of low E2: joint pain/cracking, dry skin, low libido, depressed mood, worsened lipids
Key principle: Treat symptoms, not the number. Many athletes function well across a wide ratio range.
References:
- Baggish, A. L., Weiner, R. B., Kanayama, G., et al. (2017). Cardiovascular toxicity of illicit anabolic-androgenic steroid use. Circulation, 135(21), 1991-2002. DOI: 10.1161/CIRCULATIONAHA.116.026945
- Kanayama, G., Hudson, J. I., & Pope, H. G., Jr. (2008). Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse. Drug and Alcohol Dependence, 98(1-2), 1-12. DOI: 10.1016/j.drugalcdep.2008.05.004
History Chart
Reading History
Frequently Asked Questions
Reference Ranges
Standard Range
VitalMetrics Range